Nikitas J, Rettig M, Shen J, Reiter R, et al. Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial. Eur Urol 2024 Mar 16:S0302-2838(24)00058-7. doi: 10.1016/j.eururo.2024.
PMID: 38494380